Page 73 - Genentech News Today

Genentech, Roche, and Biogen filed a Complaint on November 17 against Dr. Reddy's Laboratories ("DRL") and Fresenius in the U.S. District Court for the District of New Jersey...

Rising prescription drug prices and fast approvals can harm patients, as highlighted by the House Committee on Oversight and Reform in December 2021.

Genentech and NVIDIA join forces to revolutionize drug discovery through the power of artificial intelligence (AI). This strategic AI...

InnovationRx is your weekly digest of healthcare news. Sign up!

Clinical trials are promising for a protection against some forms of cancer

As AI and new imaging tools give researchers vast amounts of data on tumors, they are winning some battles against this complex disease.

- Collaboration leverages expertise in artificial intelligence from Genentech and NVIDIA to unlock scientific innovation and empower R&D at a scale previously unattainable in pursuit of novel...

Genentech, a member of the Roche Group, is pioneering the use of generative AI to discover and develop new therapeutics and deliver treatments to patients more efficiently. ...

New York, USA, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Peripheral T-Cell Lymphoma Market to Observe Growth at a CAGR of 4.9% in the US by 2032 | DelveInsight The rapid growth in the peripheral T-cell lymphoma market

Roche announced on Tuesday that its biotech subsidiary Genentech has signed a multi-year AI collaboration agreement with US chipmaker Nvidia.The Swiss laboratory explains that this partnership aims to...